CLINICAL_TRIALS
trial_result
· 2014-05-12
Clinical Trial Update: Dietary Supplement of LEHEL for the Patients With Type 2 Diabetes [EARLY_Phase 1]
Summary
A Phase 1 (early) trial evaluating the LEHEL dietary supplement in patients with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shaoguan University | Conditions: Type 2 Diabetes | EARLY_Phase 1 | Status: COMPLETED